Cardiac arrhythmia and immune response in COVID-19 patients (Wang et al., 2023) is a narrative review synthesizing the incidence, types, and proposed mechanisms of COVID-19-associated arrhythmias .
The review aggregates figures from cited case series: overall arrhythmia 6-17% (44% in ICU), atrial fibrillation in 15-30% of patients, ventricular tachycardia/fibrillation in 5.9% of 187 hospitalized patients, 71.9% tachycardia independent of fever/hypotension in 121 patients, palpitations in 7.3% of 137 patients, electrolyte disorders in 7.2%, and cardiac-injury-associated mortality of 59.6% vs 8.9% without injury .
Note: midpoint values are shown for the 6-17% and 15-30% ranges; these are author-reported figures from varied study designs, populations, and monitoring intensity and are not directly comparable.
The review proposes a multifactorial framework: hypoxia-induced intracellular calcium overload via sodium-hydrogen exchanger dysregulation, connexin-43 dephosphorylation reducing electrical coupling, cytokine-mediated channel dysfunction (IL-6, TNF-Ξ±, IL-1 prolonging ventricular action potentials and inhibiting CYP450, increasing QT-drug bioavailability), ACE2-mediated angiotensin II accumulation causing adverse remodeling, right-heart stress from pulmonary embolism/ARDS, and QT-prolonging treatments (hydroxychloroquine, azithromycin, lopinavir/ritonavir) .
Verdict: a readable, mechanistically broad but methodologically weak synthesis; useful as a teaching overview, not as quantitative evidence.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.